Susquehanna International Group, LLP Athira Pharma, Inc. Call Options Transaction History

Susquehanna International Group, LLP

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$0.42 - $3.43 $15,288 - $124,852	36,400 Added 70.27%	88,200 $39,000
Q2 2024 Aug 15, 2024	SELL	$1.92 - $2.71 $31,680 - $44,715	-16,500 Reduced 24.16%	51,800 $137,000
Q1 2024 May 07, 2024	BUY	$2.24 - $4.15 $7,168 - $13,280	3,200 Added 4.92%	68,300 $187,000
Q3 2023 Nov 14, 2023	SELL	$1.9 - $3.16 $5,510 - $9,164	-2,900 Reduced 4.26%	65,100 $131,000
Q2 2023 Aug 11, 2023	SELL	$2.36 - $3.59 $2,124 - $3,231	-900 Reduced 1.31%	68,000 $200,000
Q1 2023 May 16, 2023	SELL	$2.26 - $4.22 $33,900 - $63,299	-15,000 Reduced 17.88%	68,900 $172,000
Q4 2022 Feb 14, 2023	SELL	$2.76 - $3.71 $85,008 - $114,268	-30,800 Reduced 26.85%	83,900 $265,000
Q3 2022 Nov 14, 2022	SELL	$2.93 - $3.96 $1.17 Million - $1.58 Million	-398,100 Reduced 77.63%	114,700 $341,000
Q2 2022 Aug 15, 2022	BUY	$2.74 - $13.43 $7,946 - $38,947	2,900 Added 0.57%	512,800 $1.56 Million
Q1 2022 May 16, 2022	BUY	$8.96 - $13.51 $2.58 Million - $3.89 Million	288,200 Added 130.0%	509,900 $6.88 Million
Q4 2021 Feb 14, 2022	BUY	$9.17 - $16.39 $1.77 Million - $3.16 Million	192,500 Added 659.25%	221,700 $2.89 Million
Q3 2021 Nov 15, 2021	SELL	$9.15 - $11.09 $812,520 - $984,792	-88,800 Reduced 75.25%	29,200 $274,000
Q2 2021 Aug 11, 2021	BUY	$10.24 - $20.87 $1.21 Million - $2.46 Million	118,000 New	118,000 $1.21 Million

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $25.3M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.